Recommendations concerning neuropsychiatric symptoms assessment

Area of Science:

• Neuroscience
• Gerontology
• Psychiatry

Background:

• Neuropsychiatric symptoms are prevalent in dementia, significantly impacting patient care and caregiver burden.
• These symptoms are increasingly recognized as integral to dementia and neurodegenerative disease processes.
• Current dementia research, particularly for Alzheimer's Disease (AD), requires robust assessment tools.

Purpose of the Study:

• To identify suitable neuropsychiatric assessments for long-term clinical trials in Alzheimer's Disease (AD).
• To establish criteria for ideal markers in disease-modifying AD therapeutic trials.
• To focus on markers effective in early and prodromal stages of AD.

Main Methods:

• Review of existing literature on neuropsychiatric assessments in dementia.
• Definition of criteria for ideal markers in clinical trials.
• Focus on sensitivity, reliability, validity, and correlation with disease progression and neuropathology.

Main Results:

• Ideal markers must be valid, reliable, and sensitive to change.
• Markers should correlate with disease progression and neuropathology.
• Emphasis on suitability for early and prodromal stages of Alzheimer's Disease.

Conclusions:

• Neuropsychiatric assessments are crucial for evaluating disease-modifying therapies in AD.
• The selection of appropriate markers is vital for successful long-term AD trials.
• Future research should prioritize markers that capture early-stage AD changes effectively.